TherapeuticsMD
TXMD
$1.86
Share price
-0.53%
Change (1 day)
-47.31%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - Net assets
Net assets on the balance sheet as of September 2023 : $28.05 M
According to TherapeuticsMD's latest financial reports the company has $28.05 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
TherapeuticsMD - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $35.14 M | -137.54% |
| 2021-12-31 | $-93.63 M | -24.5% |
| 2020-12-31 | $-0.13 B | -1447.67% |
| 2019-12-31 | $9.2 M | -90.57% |
| 2018-12-31 | $97.52 M | -24.93% |
| 2017-12-31 | $0.12 B | 1.9% |
| 2016-12-31 | $0.12 B | 102.16% |
| 2015-12-31 | $63.06 M | 30.33% |
| 2014-12-31 | $48.38 M | -11.53% |
| 2013-12-31 | $54.69 M | -3916.71% |
| 2012-12-31 | $-1.44 M | -16.28% |
| 2011-12-31 | $-1.72 M | -277.5% |
| 2010-12-31 | $0.96 M | -410.05% |
| 2009-12-31 | $-0.32 M | -1763.65% |
| 2008-12-31 | $0.01 M | -95.52% |
| 2007-12-31 | $0.41 M | -75.25% |
| 2006-12-31 | $1.68 M | 28.38% |
| 2005-12-31 | $1.31 M | 25% |
| 2004-12-31 | $1.05 M | 21.4% |
| 2003-12-31 | $0.86 M | 17.61% |
| 2002-12-31 | $0.73 M | 9.57% |
| 2001-12-31 | $0.67 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 318,194.60% | 🇺🇸 USA |
 AbbVie ABBV | $10.39 B | 36,963.31% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$12.42 M | -144.24% | 🇺🇸 USA |
 Royalty Pharma RPRX | $10.08 B | 35,848.60% | 🇬🇧 UK |
 Lannett Company LCI | -$0.42 B | -1,569.62% | 🇺🇸 USA |